Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Haematologica|March 28, 2008
Front-line treatment of Philadelphia positive chronic myeloid leukemia with imatinib and interferon-alpha: 5-year outcomeFrancesca Palandri, Ilaria Iacobucci, Fausto Castagnetti, et al.
Haematologica|May 10, 2007
Clearance of minimal residual disease after allogeneic stem cell transplantation and the prediction of the clinical outcome of adult patients with high-risk acute lymphoblastic leukemiaOrietta Spinelli, Barbara Peruta, Manuela Tosi, et al.
Blood Research|August 15, 2020
Use of generic imatinib as first-line treatment in patients with chronic myeloid leukemia (CML): the GIMS (Glivec to Imatinib Switch) studyMaria Gemelli, Elena Maria Elli, Chiara Elena, et al.
Haematologica|June 12, 2013
High cure rates in Burkitt lymphoma and leukemia: a Northern Italy Leukemia Group study of the German short intensive rituximab-chemotherapy programTamara Intermesoli, Alessandro Rambaldi, Giuseppe Rossi, et al.
Acta Haematologica|September 18, 2024
Bosutinib Treatment of Chronic Myeloid Leukemia in LombardyAlessandra Iurlo, Cristina Bucelli, Tamara Intermesoli, et al.
Leukemia|December 22, 2018
Health-related quality of life, symptom burden, and comorbidity in long-term survivors of acute promyelocytic leukemiaFabio Efficace, Massimo Breccia, Giuseppe Avvisati, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2010
Chemotherapy-phased imatinib pulses improve long-term outcome of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: Northern Italy Leukemia Group protocol 09/00Renato Bassan, Giuseppe Rossi, Enrico M Pogliani, et al.
Cancer|January 3, 2014
Drug resistance and BCR-ABL kinase domain mutations in Philadelphia chromosome-positive acute lymphoblastic leukemia from the imatinib to the second-generation tyrosine kinase inhibitor era: The main changes are in the type of mutations, but not in the frequency of mutation involvementSimona Soverini, Caterina De Benedittis, Cristina Papayannidis, et al.
Oncoscience|January 17, 2015
Genomic quantitative real-time PCR proves residual disease positivity in more than 30% samples with negative mRNA-based qRT-PCR in Chronic Myeloid LeukemiaIlaria S Pagani, Orietta Spinelli, Elia Mattarucchi, et al.
Haematologica|October 19, 2010
Liposomal cytarabine is effective and tolerable in the treatment of central nervous system relapse of acute lymphoblastic leukemia and very aggressive lymphomaNicola Gökbuget, Christina-Maria Hartog, Renato Bassan, et al.
Pageof 5